Adjuvant chemo-immunotherapy may benefit patients with resected stage IB–IIIA NSCLC, trial suggests
Interim results from the NADIM ADJUVANT Phase III trial, led by the Spanish Lung Cancer Group (GECP), suggest…
Council Slashes GST On Key Medicines
How Patients Gain For families struggling with treatment bills, this comes across as a huge relief. Previously, a…